RSV shot approved for infants: What to know

The FDA on Monday approved a new preventative treatment for respiratory syncytial virus (RSV), the leading cause of infant hospitalization in the US.

Related Keywords

,Atlantic Derek Thompson ,Helen Chu ,Glaxosmithkline Arexvy ,Keren Landman ,Jason Mclellan ,Pfizer ,Astrazeneca ,Derek Thompson ,